Propranolol (Cardiovascular)

Generic name: Pronounced as (proe pran' oh lole)
Brand names
  • Inderal®
  • Inderal® LA
  • Inderal® XL
  • InnoPran®
  • InnoPran® XL
  • Pronol®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 08/15/2017

Do not stop taking propranolol without talking to your doctor first. If propranolol is stopped suddenly, it may cause chest pain or heart attack in some people.

Propranolol is used to treat high blood pressure, irregular heart rhythms, pheochromocytoma (tumor on a small gland near the kidneys), certain types of tremor, and hypertrophic subaortic stenosis (a heart muscle disease). It is also used to prevent angina (chest pain), migraine headaches, and to improve survival after a heart attack. Propranolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure.

High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Propranolol comes as a tablet, solution (liquid),and as an extended-release (long-acting) capsule to take by mouth. The extended-release propranolol capsule (brand name: Inderal LA) usually is taken once a day. The extended-release capsule (Innopran XL, Inderal XL) is usually taken at bedtime and should consistently be taken either always with or always without food each time. Immediate-acting propranolol tablets or solution may be taken two, three, or four times a day. Take propranolol at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take propranolol exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the extended-release capsules whole; do not split, chew, or crush them.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking propranolol,

  • tell your doctor and pharmacist if you are allergic to propranolol, any other medications, or any ingredients in propranolol products. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: ACE inhibitors; antacids containing aluminum (Maalox, Mylanta, others); anticoagulants (''blood thinners'') such as warfarin (Coumadin, Jantoven); calcium channel blockers such as diltiazem (Cardizem, Cartia, Tiazac, others), nicardipine (Cardene), nifedipine (Adalat, Procardia XL), and nisoldipine (Sular); cholestyramine (Prevalite); cimetidine; ciprofloxacin (Cipro); chlorpromazine; colestipol (Colestid); diazepam (Diastat, Valium); digoxin (Lanoxin); fluvoxamine (Luvox); haloperidol (Haldol); HMG-CoA reductase inhibitors (cholesterol-lowering agents) such as lovastatin (Altoprev, Mevacor, in Advicor) and pravastatin (Pravachol); isoniazid (in Rifamate, in Rifater); medications for depression such as bupropion (Aplenzin, Forfivo XL, Wellbutrin, Zyban), fluoxetine (Prozac, Sarafem, Selfemra), imipramine (Tofranil), and paroxetine (Brisdelle, Paxil, Pexeva); fluconazole (Diflucan); medications for migraine headaches such as rizatriptan (Maxalt) and zolmitriptan (Zomig); medications for high blood pressure such as clonidine (Catapres, Kapvay, in Clorpres), doxazosin (Cardura), prazosin (Minipress), and terazosin; medications for seizures such as phenytoin (Dilantin, Phenytek) and phenobarbital; certain medications for irregular heartbeats such as amiodarone (Cordarone, Nexterone, Pacerone), propafenone (Rythmol), and quinidine (in Nuedexta); monoamine oxidase (MAO) inhibitors such as phenelzine (Nardil); montelukast (Singulair); nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin (Indocin, Tivorbex); theophylline (Theo-24, Theochron, Uniphyl); reserpine; rifampin (Rifadin, Rimactane, in Rifater, in Rifamate); ritonavir (Norvir, in Kaletra, in Viekira Pak); teniposide (Vumon); thioridazine; ticlopidine; tolbutamide; tricyclic antidepressants; and zileuton (Zyflo). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had asthma or other lung disease; heart, liver, or kidney disease; diabetes; severe allergies; or thyroid problems.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking propranolol, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking propranolol.

  • ask your doctor about the safe use of alcoholic beverages while you are taking propranolol. Alcohol may increase the amount of propranolol in your body.

  • tell your doctor if you use tobacco products. Cigarette smoking may decrease the effectiveness of this medication.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Propranolol may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • dizziness or lightheadedness

    • tiredness

    • diarrhea

    • constipation

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately or get emergency medical treatment:

    • difficulty breathing or swallowing

    • rash

    • blistering or peeling skin

    • hives

    • itching

    • swelling of the face, throat, tongue, or lips

    • feeling faint

    • weight gain

    • irregular heartbeat

  • Propranolol may cause other side effects. Call your doctor if you have any unusual problems while you are using this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from light, excess heat, and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • slow heartbeat

Keep all appointments with your doctor and the laboratory.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Inderide® (containing Hydrochlorothiazide, Propranolol)
  • Inderide® LA (containing Hydrochlorothiazide, Propranolol)

Drug Interaction
Moxifloxacin Moxifloxacin The metabolism of Propranolol can be decreased when combined with Moxifloxacin.
Repaglinide Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Propranolol.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin glargine.
Leflunomide Leflunomide The serum concentration of Propranolol can be decreased when it is combined with Leflunomide.
Delavirdine Delavirdine The serum concentration of Propranolol can be increased when it is combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Propranolol can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Propranolol.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Propranolol is combined with Dolasetron.
Aminophylline Aminophylline The risk or severity of adverse effects can be increased when Propranolol is combined with Aminophylline.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Propranolol is combined with Anagrelide.
Calcium Carbonate Calcium Carbonate The therapeutic efficacy of Propranolol can be decreased when used in combination with Calcium carbonate.
Candesartan Candesartan The risk or severity of hyperkalemia can be increased when Propranolol is combined with Candesartan.
Cilostazol Cilostazol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Propranolol.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Propranolol.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Propranolol can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The metabolism of Propranolol can be decreased when combined with Conjugated estrogens.
Fenofibrate Fenofibrate The serum concentration of Propranolol can be increased when it is combined with Fenofibrate.
Guanfacine Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Propranolol.
Magnesium Hydroxide Magnesium Hydroxide Propranolol may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine Methylergonovine Propranolol may increase the vasoconstricting activities of Methylergometrine.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Propranolol.
Mycophenolate Mycophenolate Propranolol may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan Naratriptan The metabolism of Naratriptan can be decreased when combined with Propranolol.
Olsalazine Olsalazine Olsalazine may decrease the antihypertensive activities of Propranolol.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Propranolol.
Penbutolol Penbutolol Propranolol may increase the arrhythmogenic activities of Acebutolol.
Potassium Potassium Potassium may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Propranolol may decrease the excretion rate of Prednisone which could result in a higher serum level.
Ranitidine Ranitidine The serum concentration of Ranitidine can be increased when it is combined with Propranolol.
Reserpine Reserpine Reserpine may increase the hypotensive activities of Propranolol.
Rizatriptan Rizatriptan The metabolism of Rizatriptan can be decreased when combined with Propranolol.
Sumatriptan Sumatriptan The metabolism of Sumatriptan can be decreased when combined with Propranolol.
Tacrolimus Tacrolimus The metabolism of Tacrolimus can be decreased when combined with Propranolol.
Tizanidine Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Propranolol.
Triamcinolone Triamcinolone The metabolism of Propranolol can be increased when combined with Triamcinolone.
Zolmitriptan Zolmitriptan The serum concentration of the active metabolites of Zolmitriptan can be reduced when Zolmitriptan is used in combination with Propranolol resulting in a loss in efficacy.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Propranolol which could result in a higher serum level.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Propranolol.
Fluconazole Injection Fluconazole Injection The serum concentration of Propranolol can be increased when it is combined with Fluconazole.
Foscarnet Injection Foscarnet Injection The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Propranolol.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Propranolol which could result in a higher serum level.
Interferon Beta-1b Injection Interferon Beta-1b Injection The metabolism of Propranolol can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The metabolism of Propranolol can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection Levofloxacin Injection The metabolism of Propranolol can be decreased when combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Propranolol can be increased when combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The metabolism of Propranolol can be decreased when combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Propranolol is combined with Metronidazole.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Propranolol.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Propranolol which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Propranolol may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine The therapeutic efficacy of Propranolol can be decreased when used in combination with Amphetamine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Propranolol.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Propranolol is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Propranolol is combined with Granisetron.
Torsemide Torsemide Torasemide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The serum concentration of Propranolol can be increased when it is combined with Olanzapine.
Alosetron Alosetron The metabolism of Propranolol can be decreased when combined with Alosetron.
Dofetilide Dofetilide Propranolol may increase the arrhythmogenic activities of Dofetilide.
Entacapone Entacapone The metabolism of Propranolol can be decreased when combined with Entacapone.
Eprosartan Eprosartan The risk or severity of hyperkalemia can be increased when Propranolol is combined with Eprosartan.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Propranolol.
Meloxicam Meloxicam Meloxicam may decrease the antihypertensive activities of Propranolol.
Oxcarbazepine Oxcarbazepine The serum concentration of Propranolol can be increased when it is combined with Oxcarbazepine.
Pantoprazole Pantoprazole The serum concentration of Propranolol can be increased when it is combined with Pantoprazole.
Sevelamer Sevelamer Sevelamer can cause a decrease in the absorption of Propranolol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan The serum concentration of Propranolol can be increased when it is combined with Telmisartan.
Temozolomide Temozolomide Propranolol may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Propranolol may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra Anakinra The metabolism of Propranolol can be increased when combined with Anakinra.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Desloratadine.
Linezolid Linezolid Linezolid may increase the hypotensive activities of Propranolol.
Rivastigmine Rivastigmine Propranolol may increase the bradycardic activities of Rivastigmine.
Trimipramine Trimipramine The metabolism of Propranolol can be decreased when combined with Trimipramine.
Etanercept Injection Etanercept Injection The metabolism of Propranolol can be increased when combined with Etanercept.
Modafinil Modafinil The serum concentration of Propranolol can be increased when it is combined with Modafinil.
Perindopril Perindopril Propranolol may increase the hypotensive activities of Perindopril.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the antihypertensive activities of Propranolol.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Propranolol.
Dutasteride Dutasteride The metabolism of Dutasteride can be decreased when combined with Propranolol.
Epinephrine Injection Epinephrine Injection Propranolol may decrease the bronchodilatory activities of Epinephrine.
Eplerenone Eplerenone Propranolol may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram Escitalopram The serum concentration of Escitalopram can be increased when it is combined with Propranolol.
Olmesartan Olmesartan The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Propranolol.
Zonisamide Zonisamide The serum concentration of Propranolol can be increased when it is combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Propranolol can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The risk or severity of hypotension can be increased when Aripiprazole is combined with Propranolol.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Propranolol.
Dexmethylphenidate Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Propranolol.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Almotriptan Almotriptan The metabolism of Almotriptan can be decreased when combined with Propranolol.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Propranolol.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be decreased when Mefloquine is combined with Propranolol.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Propranolol.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Propranolol is combined with Vardenafil.
Alfuzosin Alfuzosin Alfuzosin may increase the hypotensive activities of Propranolol.
Aprepitant Aprepitant The serum concentration of Propranolol can be increased when it is combined with Aprepitant.
Emtricitabine Emtricitabine Propranolol may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Interferon Beta-1a Subcutaneous Injection Interferon Beta-1a Subcutaneous Injection The metabolism of Propranolol can be decreased when combined with Interferon beta-1a.
Memantine Memantine The serum concentration of Propranolol can be increased when it is combined with Memantine.
Tegaserod Tegaserod The metabolism of Propranolol can be decreased when combined with Tegaserod.
Tadalafil Tadalafil Propranolol may increase the antihypertensive activities of Tadalafil.
Frovatriptan Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Propranolol.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Propranolol is combined with Gemifloxacin.
Progesterone Progesterone The serum concentration of Propranolol can be increased when it is combined with Progesterone.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Propranolol.
Infliximab Injection Infliximab Injection The metabolism of Propranolol can be increased when combined with Infliximab.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Propranolol.
Rifaximin Rifaximin The serum concentration of Propranolol can be decreased when it is combined with Rifaximin.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Propranolol is combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Propranolol can be decreased when combined with Norethisterone.
Tinidazole Tinidazole Propranolol may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Trospium Trospium The metabolism of Propranolol can be decreased when combined with Trospium.
Bosentan Bosentan Bosentan may increase the hypotensive activities of Propranolol.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cinacalcet Cinacalcet The metabolism of Propranolol can be decreased when combined with Cinacalcet.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Propranolol.
Eszopiclone Eszopiclone Eszopiclone may decrease the excretion rate of Propranolol which could result in a higher serum level.
Ganciclovir Ganciclovir Propranolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin aspart.
Ribavirin Ribavirin Propranolol may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Propranolol.
Valganciclovir Valganciclovir Propranolol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The serum concentration of Propranolol can be increased when it is combined with Voriconazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine The therapeutic efficacy of Propranolol can be decreased when used in combination with Amphetamine.
Entecavir Entecavir The metabolism of Propranolol can be decreased when combined with Entecavir.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The metabolism of Propranolol can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Propranolol can be increased when it is combined with Peginterferon alfa-2b.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Propranolol.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Propranolol.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Propranolol.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the hypotensive activities of Propranolol.
Ramelteon Ramelteon The metabolism of Ramelteon can be decreased when combined with Propranolol.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Propranolol.
Fentanyl Fentanyl Fentanyl may decrease the antihypertensive activities of Propranolol.
Pregabalin Pregabalin Pregabalin may increase the arrhythmogenic activities of Propranolol.
Deferasirox Deferasirox The serum concentration of Propranolol can be increased when it is combined with Deferasirox.
Phenylephrine Phenylephrine The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Propranolol.
Tipranavir Tipranavir The serum concentration of Propranolol can be increased when it is combined with Tipranavir.
Felbamate Felbamate The serum concentration of Propranolol can be increased when it is combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin detemir.
Ranolazine Ranolazine The serum concentration of Ranolazine can be increased when it is combined with Propranolol.
Abatacept Injection Abatacept Injection The metabolism of Propranolol can be increased when combined with Abatacept.
Rasagiline Rasagiline Rasagiline may increase the hypotensive activities of Propranolol.
Imatinib Imatinib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Imatinib.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Propranolol.
Varenicline Varenicline The excretion of Varenicline can be decreased when combined with Propranolol.
Gefitinib Gefitinib The serum concentration of Propranolol can be increased when it is combined with Gefitinib.
Albuterol Albuterol Propranolol may decrease the bronchodilatory activities of Salbutamol.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Propranolol is combined with Paliperidone.
Bortezomib Bortezomib The serum concentration of Propranolol can be increased when it is combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The serum concentration of Clofarabine can be increased when it is combined with Propranolol.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin glulisine.
Lubiprostone Lubiprostone Propranolol may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The serum concentration of Oxaliplatin can be increased when it is combined with Propranolol.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Propranolol.
Primaquine Primaquine The metabolism of Propranolol can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection Propranolol may increase the hypotensive activities of Rituximab.
Aliskiren Aliskiren The risk or severity of hyperkalemia can be increased when Propranolol is combined with Aliskiren.
Pemetrexed Injection Pemetrexed Injection Propranolol may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Propranolol is combined with Dimenhydrinate.
Lisdexamfetamine Lisdexamfetamine The therapeutic efficacy of Propranolol can be decreased when used in combination with Lisdexamfetamine.
Nabilone Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Propranolol.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Propranolol.
Sorafenib Sorafenib The serum concentration of Propranolol can be increased when it is combined with Sorafenib.
Sunitinib Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Propranolol.
Lapatinib Lapatinib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Propranolol.
Pegaptanib Injection Pegaptanib Injection Propranolol may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Propranolol.
Mexiletine Mexiletine Mexiletine may increase the arrhythmogenic activities of Propranolol.
Armodafinil Armodafinil The serum concentration of Propranolol can be increased when it is combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Propranolol may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Temsirolimus Temsirolimus The metabolism of Propranolol can be decreased when combined with Temsirolimus.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Propranolol which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Propranolol.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Propranolol is combined with Toremifene.
Budesonide Budesonide The metabolism of Propranolol can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The serum concentration of Propranolol can be increased when it is combined with Chloramphenicol.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Betaine Betaine Glycine betaine may increase the bradycardic activities of Propranolol.
Doripenem Injection Doripenem Injection Propranolol may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The serum concentration of Propranolol can be increased when it is combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Propranolol is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine The serum concentration of Propranolol can be increased when it is combined with Desvenlafaxine.
Cevimeline Cevimeline The risk or severity of adverse effects can be increased when Cevimeline is combined with Propranolol.
Nebivolol Nebivolol Propranolol may increase the arrhythmogenic activities of Nebivolol.
Tretinoin Tretinoin The metabolism of Tretinoin can be decreased when combined with Propranolol.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Propranolol.
Pilocarpine Pilocarpine The risk or severity of adverse effects can be increased when Propranolol is combined with Pilocarpine.
Flecainide Flecainide Propranolol may increase the arrhythmogenic activities of Flecainide.
Certolizumab Injection Certolizumab Injection The metabolism of Propranolol can be increased when combined with Certolizumab pegol.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Propranolol.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Praziquantel Praziquantel The metabolism of Praziquantel can be decreased when combined with Propranolol.
Methylnaltrexone Injection Methylnaltrexone Injection Propranolol may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Silodosin Silodosin Propranolol may increase the orthostatic hypotensive activities of Silodosin.
Midazolam Midazolam Propranolol may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Propranolol which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Eltrombopag can be decreased when combined with Propranolol.
Milnacipran Milnacipran The serum concentration of Propranolol can be increased when it is combined with Milnacipran.
Dexlansoprazole Dexlansoprazole The metabolism of Propranolol can be decreased when combined with Dexlansoprazole.
Plerixafor Injection Plerixafor Injection Propranolol may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate Sodium phosphate, monobasic may increase the hyperkalemic activities of Propranolol.
Fesoterodine Fesoterodine Propranolol may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Propranolol.
Betaxolol Betaxolol Betaxolol may increase the arrhythmogenic activities of Propranolol.
Iloperidone Iloperidone The risk or severity of QTc prolongation can be increased when Propranolol is combined with Iloperidone.
Prasugrel Prasugrel Propranolol may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Propranolol.
Everolimus Everolimus The metabolism of Propranolol can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone Dronedarone may increase the bradycardic activities of Propranolol.
Pralatrexate Injection Pralatrexate Injection Propranolol may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Propranolol which could result in a higher serum level.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Propranolol.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Propranolol is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Propranolol is combined with Romidepsin.
Tapentadol Tapentadol The metabolism of Propranolol can be decreased when combined with Tapentadol.
Topotecan Topotecan Propranolol may decrease the excretion rate of Topotecan which could result in a higher serum level.
Golimumab Injection Golimumab Injection The metabolism of Propranolol can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Propranolol.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Asenapine.
Albendazole Albendazole The metabolism of Propranolol can be decreased when combined with Albendazole.
Levonorgestrel Levonorgestrel The metabolism of Propranolol can be decreased when combined with Levonorgestrel.
Oxymorphone Oxymorphone The metabolism of Oxymorphone can be decreased when combined with Propranolol.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Propranolol.
Tocilizumab Injection Tocilizumab Injection The metabolism of Propranolol can be increased when combined with Tocilizumab.
Dalfampridine Dalfampridine The serum concentration of Dalfampridine can be increased when it is combined with Propranolol.
Fingolimod Fingolimod Propranolol may increase the bradycardic activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Propranolol.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Propranolol.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Propranolol which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Propranolol.
Acetaminophen Injection Acetaminophen Injection The metabolism of Propranolol can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Propranolol can be decreased when combined with Vilazodone.
Ipilimumab Injection Ipilimumab Injection Propranolol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Propranolol may decrease the bronchodilatory activities of Terbutaline.
Azilsartan Azilsartan The risk or severity of hyperkalemia can be increased when Propranolol is combined with Azilsartan medoxomil.
Roflumilast Roflumilast Propranolol may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Propranolol.
Rilpivirine Rilpivirine The metabolism of Rilpivirine can be decreased when combined with Propranolol.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Propranolol.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Propranolol can be decreased when combined with Cyclophosphamide.
Abiraterone Abiraterone The serum concentration of Propranolol can be increased when it is combined with Abiraterone.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Propranolol.
Rivaroxaban Rivaroxaban Propranolol may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ruxolitinib Ruxolitinib Ruxolitinib may increase the bradycardic activities of Propranolol.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Vandetanib.
Clobazam Clobazam The metabolism of Propranolol can be decreased when combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Propranolol can be increased when it is combined with Vemurafenib.
Vismodegib Vismodegib The serum concentration of Propranolol can be increased when it is combined with Vismodegib.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Propranolol.
Deferiprone Deferiprone Propranolol may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Propranolol.
Crizotinib Crizotinib The metabolism of Propranolol can be decreased when combined with Crizotinib.
Cabergoline Cabergoline Propranolol may increase the vasoconstricting activities of Cabergoline.
Naloxone Injection Naloxone Injection Propranolol may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Propranolol.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Propranolol which could result in a higher serum level.
Iloprost Iloprost Iloprost may increase the hypotensive activities of Propranolol.
Enzalutamide Enzalutamide The serum concentration of Propranolol can be decreased when it is combined with Enzalutamide.
Mirabegron Mirabegron The metabolism of Mirabegron can be decreased when combined with Propranolol.
Regorafenib Regorafenib Regorafenib may increase the bradycardic activities of Propranolol.
Teriflunomide Teriflunomide The serum concentration of Propranolol can be decreased when it is combined with Teriflunomide.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Propranolol.
Teduglutide Injection Teduglutide Injection Propranolol may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Propranolol is combined with Bedaquiline.
Tofacitinib Tofacitinib Propranolol may increase the bradycardic activities of Tofacitinib.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Propranolol.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Propranolol.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Propranolol.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Propranolol.
Apixaban Apixaban The metabolism of Apixaban can be decreased when combined with Propranolol.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Propranolol.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The serum concentration of Dabrafenib can be decreased when it is combined with Propranolol.
Ospemifene Ospemifene The metabolism of Propranolol can be decreased when combined with Ospemifene.
Trametinib Trametinib Propranolol may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran The serum concentration of Propranolol can be increased when it is combined with Levomilnacipran.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Propranolol which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be decreased when combined with Propranolol.
Perampanel Perampanel The metabolism of Perampanel can be decreased when combined with Propranolol.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Propranolol.
Avanafil Avanafil Avanafil may increase the antihypertensive activities of Propranolol.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the antihypertensive activities of Propranolol.
Obinutuzumab Injection Obinutuzumab Injection Propranolol may increase the hypotensive activities of Obinutuzumab.
Simeprevir Simeprevir The metabolism of Propranolol can be decreased when combined with Simeprevir.
Sofosbuvir Sofosbuvir Propranolol may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Propranolol can be increased when used in combination with Dapagliflozin.
Apremilast Apremilast The metabolism of Propranolol can be increased when combined with Apremilast.
Droxidopa Droxidopa Propranolol may decrease the bronchodilatory activities of Droxidopa.
Ceritinib Ceritinib Propranolol may increase the bradycardic activities of Ceritinib.
Siltuximab Injection Siltuximab Injection The metabolism of Propranolol can be increased when combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Propranolol.
Eslicarbazepine Eslicarbazepine The serum concentration of Propranolol can be increased when it is combined with Eslicarbazepine.
Belinostat Injection Belinostat Injection The metabolism of Propranolol can be increased when combined with Belinostat.
Testosterone Injection Testosterone Injection Testosterone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Oritavancin Injection Oritavancin Injection The serum concentration of Propranolol can be increased when it is combined with Oritavancin.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Propranolol.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Propranolol.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Propranolol.
Edoxaban Edoxaban Propranolol may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The metabolism of Propranolol can be decreased when combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Propranolol.
Methamphetamine Methamphetamine The therapeutic efficacy of Propranolol can be decreased when used in combination with Metamfetamine.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Propranolol.
Riociguat Riociguat Propranolol may increase the hypotensive activities of Riociguat.
Lanreotide Injection Lanreotide Injection Propranolol may increase the bradycardic activities of Lanreotide.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Propranolol.
Secukinumab Injection Secukinumab Injection The metabolism of Propranolol can be increased when combined with Secukinumab.
Risperidone Injection Risperidone Injection Propranolol may increase the hypotensive activities of Risperidone.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin human.
Lenvatinib Lenvatinib The serum concentration of Propranolol can be increased when it is combined with Lenvatinib.
Naloxegol Naloxegol The serum concentration of Propranolol can be increased when it is combined with Naloxegol.
Panobinostat Panobinostat The metabolism of Propranolol can be decreased when combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Propranolol.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Propranolol.
Ivabradine Ivabradine Propranolol may increase the bradycardic activities of Ivabradine.
Amiloride Amiloride Propranolol may increase the excretion rate of Amiloride which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Propranolol may decrease the excretion rate of Macitentan which could result in a higher serum level.
Flibanserin Flibanserin Flibanserin may decrease the antihypertensive activities of Propranolol.
Rolapitant Rolapitant The metabolism of Propranolol can be decreased when combined with Rolapitant.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be decreased when combined with Propranolol.
Brexpiprazole Brexpiprazole Propranolol may increase the orthostatic hypotensive activities of Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ziprasidone.
Cariprazine Cariprazine Cariprazine may decrease the antihypertensive activities of Propranolol.
Penicillin G Procaine Injection Penicillin G Procaine Injection Propranolol may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin degludec.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Propranolol.
Osimertinib Osimertinib The serum concentration of Propranolol can be decreased when it is combined with Osimertinib.
Ixazomib Ixazomib Propranolol may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Rifapentine Rifapentine The serum concentration of Propranolol can be decreased when it is combined with Rifapentine.
Lesinurad Lesinurad Propranolol may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Propranolol which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The serum concentration of Propranolol can be decreased when it is combined with Dexamethasone.
Brivaracetam Injection Brivaracetam Injection Propranolol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Cobicistat Cobicistat The metabolism of Propranolol can be decreased when combined with Cobicistat.
Midodrine Midodrine The therapeutic efficacy of Midodrine can be decreased when used in combination with Propranolol.
Selexipag Selexipag Propranolol may increase the hypotensive activities of Selexipag.
Obeticholic Acid Obeticholic Acid The metabolism of Propranolol can be decreased when combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Propranolol can be decreased when combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Propranolol may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The serum concentration of Propranolol can be increased when it is combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Propranolol.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ribociclib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Propranolol.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Deutetrabenazine.
Valbenazine Valbenazine Propranolol may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The metabolism of Propranolol can be increased when combined with Deflazacort.
Safinamide Safinamide The serum concentration of Propranolol can be increased when it is combined with Safinamide.
Naldemedine Naldemedine Propranolol may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The serum concentration of Propranolol can be decreased when it is combined with Midostaurin.
Enasidenib Enasidenib The serum concentration of Propranolol can be increased when it is combined with Enasidenib.
Benznidazole Benznidazole Propranolol may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Propranolol.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Propranolol.
Acalabrutinib Acalabrutinib The metabolism of Propranolol can be decreased when combined with Acalabrutinib.
Letermovir Letermovir The serum concentration of Propranolol can be decreased when it is combined with Letermovir.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Propranolol.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The therapeutic efficacy of Ertugliflozin can be increased when used in combination with Propranolol.
Buprenorphine Injection Buprenorphine Injection The serum concentration of Propranolol can be increased when it is combined with Buprenorphine.
Apalutamide Apalutamide The serum concentration of Propranolol can be increased when it is combined with Apalutamide.
Fostamatinib Fostamatinib Fostamatinib may increase the antihypertensive activities of Propranolol.
Baricitinib Baricitinib Propranolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Propranolol.
Plazomicin Injection Plazomicin Injection Propranolol may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The risk or severity of QTc prolongation can be increased when Propranolol is combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Encorafenib.
Binimetinib Binimetinib The metabolism of Binimetinib can be decreased when combined with Propranolol.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ivosidenib.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Propranolol.
Eravacycline Injection Eravacycline Injection The metabolism of Eravacycline can be decreased when combined with Propranolol.
Doravirine Doravirine The metabolism of Doravirine can be decreased when combined with Propranolol.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Propranolol.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Propranolol.
Dacomitinib Dacomitinib The metabolism of Propranolol can be decreased when combined with Dacomitinib.
Stiripentol Stiripentol The serum concentration of Propranolol can be increased when it is combined with Stiripentol.
Gilteritinib Gilteritinib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be decreased when combined with Propranolol.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Propranolol.
Rifamycin Rifamycin The serum concentration of Propranolol can be decreased when it is combined with Rifamycin.
Prucalopride Prucalopride Propranolol may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Propranolol can be increased when combined with Emapalumab.
Siponimod Siponimod Siponimod may decrease the antihypertensive activities of Propranolol.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Esomeprazole Injection Esomeprazole Injection The serum concentration of Propranolol can be increased when it is combined with Esomeprazole.
Alpelisib Alpelisib The metabolism of Propranolol can be decreased when combined with Alpelisib.
Solriamfetol Solriamfetol The serum concentration of Solriamfetol can be increased when it is combined with Propranolol.
Triclabendazole Triclabendazole The metabolism of Propranolol can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Propranolol is combined with Entrectinib.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Propranolol.
Pitolisant Pitolisant The serum concentration of Propranolol can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The metabolism of Fedratinib can be decreased when combined with Propranolol.
Lefamulin Lefamulin Propranolol may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The serum concentration of Propranolol can be decreased when it is combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Propranolol can be increased when combined with Fosphenytoin.
Voxelotor Voxelotor The metabolism of Voxelotor can be decreased when combined with Propranolol.
Lasmiditan Lasmiditan Lasmiditan may increase the bradycardic activities of Propranolol.
Calcium Acetate Calcium Acetate The therapeutic efficacy of Propranolol can be decreased when used in combination with Calcium acetate.
Cenobamate Cenobamate The serum concentration of Propranolol can be decreased when it is combined with Cenobamate.
Selumetinib Selumetinib The metabolism of Selumetinib can be decreased when combined with Propranolol.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Propranolol.
Selpercatinib Selpercatinib Selpercatinib may decrease the antihypertensive activities of Propranolol.
Capmatinib Capmatinib The metabolism of Propranolol can be decreased when combined with Capmatinib.
Lemborexant Lemborexant The metabolism of Lemborexant can be decreased when combined with Propranolol.
Fenfluramine Fenfluramine The metabolism of Propranolol can be decreased when combined with Fenfluramine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Propranolol.
Octreotide Octreotide The serum concentration of the active metabolites of Propranolol can be increased when Propranolol is used in combination with Octreotide.
Pralsetinib Pralsetinib The metabolism of Propranolol can be decreased when combined with Pralsetinib.
Opicapone Opicapone The serum concentration of Propranolol can be decreased when it is combined with Opicapone.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Propranolol can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Propranolol.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Propranolol.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Propranolol may increase the excretion rate of Drospirenone which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine Propranolol may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Theophylline Theophylline The metabolism of Propranolol can be decreased when combined with Theophylline.
Fenoprofen Fenoprofen Fenoprofen may decrease the antihypertensive activities of Propranolol.
Indomethacin Indomethacin The serum concentration of Propranolol can be increased when it is combined with Indomethacin.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the antihypertensive activities of Propranolol.
Naproxen Naproxen Naproxen may decrease the antihypertensive activities of Propranolol.
Tolmetin Tolmetin Tolmetin may decrease the antihypertensive activities of Propranolol.
Sulindac Sulindac Sulindac may decrease the antihypertensive activities of Propranolol.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Propranolol.
Isotretinoin Isotretinoin Propranolol may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Propranolol which could result in a higher serum level.
Hydroxyurea Hydroxyurea The metabolism of Propranolol can be decreased when combined with Hydroxyurea.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Phenobarbital Phenobarbital The serum concentration of Propranolol can be decreased when it is combined with Phenobarbital.
Metaxalone Metaxalone Propranolol may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Propranolol which could result in a higher serum level.
Primidone Primidone The serum concentration of Propranolol can be decreased when it is combined with Primidone.
Methsuximide Methsuximide The serum concentration of Propranolol can be increased when it is combined with Methsuximide.
Diethylpropion Diethylpropion The therapeutic efficacy of Propranolol can be decreased when used in combination with Diethylpropion.
Chlorpromazine Chlorpromazine The metabolism of Propranolol can be decreased when combined with Chlorpromazine.
Diazepam Diazepam The serum concentration of Propranolol can be increased when it is combined with Diazepam.
Oxazepam Oxazepam Propranolol may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Propranolol may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Propranolol may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Phenoxybenzamine Phenoxybenzamine Propranolol may increase the orthostatic hypotensive activities of Phenoxybenzamine.
Carmustine Carmustine The metabolism of Propranolol can be decreased when combined with Carmustine.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Propranolol.
Codeine Codeine Codeine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Bromocriptine Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Propranolol.
Metaproterenol Metaproterenol Propranolol may decrease the bronchodilatory activities of Orciprenaline.
Tranylcypromine Tranylcypromine The serum concentration of Propranolol can be increased when it is combined with Tranylcypromine.
Phenelzine Phenelzine The serum concentration of Propranolol can be increased when it is combined with Phenelzine.
Procarbazine Procarbazine Procarbazine may increase the hypotensive activities of Propranolol.
Ergoloid Mesylates Ergoloid Mesylates Propranolol may increase the vasoconstricting activities of Ergoloid mesylate.
Tetracycline Tetracycline Propranolol may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Prochlorperazine Prochlorperazine The serum concentration of Propranolol can be increased when it is combined with Prochlorperazine.
Thioridazine Thioridazine The serum concentration of Thioridazine can be increased when it is combined with Propranolol.
Trifluoperazine Trifluoperazine The serum concentration of Propranolol can be increased when it is combined with Trifluoperazine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Dapsone Dapsone The metabolism of Propranolol can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Propranolol can be increased when used in combination with Sulfadiazine.
Oxycodone Oxycodone The metabolism of Propranolol can be decreased when combined with Oxycodone.
Methadone Methadone The metabolism of Propranolol can be decreased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be decreased when combined with Propranolol.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Propranolol.
Colestipol Colestipol Colestipol can cause a decrease in the absorption of Propranolol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Propranolol.
Ibuprofen Ibuprofen Ibuprofen may decrease the antihypertensive activities of Propranolol.
Orphenadrine Orphenadrine The metabolism of Propranolol can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The serum concentration of Propranolol can be increased when it is combined with Perphenazine.
Azathioprine Azathioprine The metabolism of Azathioprine can be decreased when combined with Propranolol.
Fluphenazine Fluphenazine The serum concentration of Propranolol can be increased when it is combined with Fluphenazine.
Phentermine Phentermine The therapeutic efficacy of Propranolol can be decreased when used in combination with Phentermine.
Methylphenidate Methylphenidate Methylphenidate may decrease the antihypertensive activities of Propranolol.
Amoxapine Amoxapine The metabolism of Propranolol can be decreased when combined with Amoxapine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the antihypertensive activities of Propranolol.
Hydrocortisone Hydrocortisone The serum concentration of Hydrocortisone can be decreased when it is combined with Propranolol.
Doxorubicin Doxorubicin The metabolism of Propranolol can be decreased when combined with Doxorubicin.
Mechlorethamine Mechlorethamine Mechlorethamine may increase the bradycardic activities of Propranolol.
Pyridostigmine Pyridostigmine Pyridostigmine may increase the bradycardic activities of Propranolol.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Carbamazepine Carbamazepine The serum concentration of Propranolol can be decreased when it is combined with Carbamazepine.
Methyldopa Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Propranolol.
Clonidine Clonidine The risk or severity of hypotension can be increased when Clonidine is combined with Propranolol.
Prazosin Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Propranolol.
Hydralazine Hydralazine Propranolol may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine The serum concentration of Propranolol can be increased when it is combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Warfarin Warfarin The serum concentration of Propranolol can be increased when it is combined with Warfarin.
Clonazepam Clonazepam Propranolol may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The risk or severity of bradycardia can be increased when Propranolol is combined with Loperamide.
Promethazine Promethazine The serum concentration of Propranolol can be increased when it is combined with Promethazine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the antihypertensive activities of Propranolol.
Daunorubicin Daunorubicin The metabolism of Propranolol can be increased when combined with Daunorubicin.
Nitrofurantoin Nitrofurantoin The risk or severity of hyperkalemia can be increased when Propranolol is combined with Nitrofurantoin.
Griseofulvin Griseofulvin The metabolism of Propranolol can be increased when combined with Griseofulvin.
Digoxin Digoxin Propranolol may increase the arrhythmogenic activities of Digoxin.
Chloroquine Chloroquine The metabolism of Propranolol can be decreased when combined with Chloroquine.
Quinine Quinine The serum concentration of Propranolol can be increased when it is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of bradycardia can be increased when Ethosuximide is combined with Propranolol.
Triamterene Triamterene The metabolism of Propranolol can be decreased when combined with Triamterene.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Propranolol.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Propranolol.
Secobarbital Secobarbital The serum concentration of Propranolol can be decreased when it is combined with Secobarbital.
Desipramine Desipramine The metabolism of Propranolol can be decreased when combined with Desipramine.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Propranolol.
Imipramine Imipramine The serum concentration of Propranolol can be increased when it is combined with Imipramine.
Probenecid Probenecid The serum concentration of Propranolol can be increased when it is combined with Probenecid.
Quinidine Quinidine The serum concentration of Propranolol can be increased when it is combined with Quinidine.
Procainamide Procainamide Propranolol may increase the arrhythmogenic activities of Procainamide.
Isoniazid Isoniazid The serum concentration of Propranolol can be increased when it is combined with Isoniazid.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Propranolol which could result in a higher serum level.
Rifampin Rifampin The serum concentration of Propranolol can be decreased when it is combined with Rifampicin.
Disopyramide Disopyramide Disopyramide may increase the bradycardic activities of Propranolol.
Valproic Acid Valproic Acid The serum concentration of Propranolol can be increased when it is combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Propranolol.
Butabarbital Butabarbital Butabarbital may increase the hypotensive activities of Propranolol.
Levothyroxine Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Propranolol.
Liothyronine Liothyronine The therapeutic efficacy of Propranolol can be decreased when used in combination with Liothyronine.
Methimazole Methimazole The excretion of Propranolol can be decreased when combined with Methimazole.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Propranolol.
Glucagon Injection Glucagon Injection The therapeutic efficacy of Propranolol can be decreased when used in combination with Glucagon.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Propranolol.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Propranolol.
Dextromethorphan Dextromethorphan The metabolism of Propranolol can be decreased when combined with Dextromethorphan.
Cyclobenzaprine Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Propranolol.
Niacin Niacin The metabolism of Propranolol can be decreased when combined with Niacin.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Propranolol.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Propranolol.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Propranolol.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Propranolol.
Meclizine Meclizine The metabolism of Meclizine can be decreased when combined with Propranolol.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Propranolol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Propranolol can be increased when used in combination with Methyclothiazide.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Propranolol is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The metabolism of Propranolol can be decreased when combined with Chlorzoxazone.
Carisoprodol Carisoprodol The metabolism of Propranolol can be decreased when combined with Carisoprodol.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Propranolol which could result in a higher serum level.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Propranolol.
Minoxidil Minoxidil Minoxidil may increase the hypotensive activities of Propranolol.
Pseudoephedrine Pseudoephedrine The therapeutic efficacy of Propranolol can be decreased when used in combination with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Propranolol can be decreased when combined with Nortriptyline.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Propranolol which could result in a higher serum level.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Propranolol is combined with Mercaptopurine.
Phytonadione Phytonadione Propranolol may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Nadolol Nadolol Propranolol may increase the arrhythmogenic activities of Nadolol.
Cholestyramine Resin Cholestyramine Resin Cholestyramine can cause a decrease in the absorption of Propranolol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Propranolol which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Propranolol.
Flavoxate Flavoxate Propranolol may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Propranolol is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Propranolol.
Colchicine Colchicine Propranolol may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Dacarbazine Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Propranolol.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Propranolol which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Ketoconazole Ketoconazole The serum concentration of Propranolol can be increased when it is combined with Ketoconazole.
Pyrantel Pyrantel Propranolol may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection Thiotepa may increase the bradycardic activities of Propranolol.
Vincristine Injection Vincristine Injection The metabolism of Propranolol can be decreased when combined with Vincristine.
Captopril Captopril The risk or severity of hyperkalemia can be increased when Propranolol is combined with Captopril.
Dipyridamole Dipyridamole Dipyridamole may increase the bradycardic activities of Propranolol.
Isoxsuprine Isoxsuprine The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Propranolol.
Vinblastine Vinblastine The metabolism of Propranolol can be decreased when combined with Vinblastine.
Bethanechol Bethanechol The risk or severity of adverse effects can be increased when Propranolol is combined with Bethanechol.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Propranolol which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Propranolol which could result in a higher serum level.
Metoprolol Metoprolol The metabolism of Propranolol can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Propranolol.
Thiothixene Thiothixene The metabolism of Thiothixene can be decreased when combined with Propranolol.
Aspirin Aspirin The serum concentration of Propranolol can be decreased when it is combined with Acetylsalicylic acid.
Salsalate Salsalate Salsalate may decrease the antihypertensive activities of Propranolol.
Alprazolam Alprazolam Alprazolam may decrease the excretion rate of Propranolol which could result in a higher serum level.
Temazepam Temazepam Temazepam may decrease the excretion rate of Propranolol which could result in a higher serum level.
Triazolam Triazolam Propranolol may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Propranolol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Hyoscyamine Hyoscyamine Hyoscyamine may increase the arrhythmogenic activities of Propranolol.
Propantheline Propantheline Propranolol may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Propranolol which could result in a higher serum level.
Diltiazem Diltiazem The risk or severity of bradycardia can be increased when Diltiazem is combined with Propranolol.
Nifedipine Nifedipine The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Propranolol.
Timolol Timolol The risk or severity of adverse effects can be increased when Timolol is combined with Propranolol.
Verapamil Verapamil The risk or severity of adverse effects can be increased when Propranolol is combined with Verapamil.
Atenolol Atenolol Atenolol may increase the arrhythmogenic activities of Propranolol.
Pindolol Pindolol The risk or severity of hyperkalemia can be increased when Propranolol is combined with Pindolol.
Cisplatin Injection Cisplatin Injection The serum concentration of Cisplatin can be increased when it is combined with Propranolol.
Diflunisal Diflunisal Diflunisal may decrease the antihypertensive activities of Propranolol.
Piroxicam Piroxicam Piroxicam may decrease the antihypertensive activities of Propranolol.
Bumetanide Bumetanide Propranolol may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Streptozocin Streptozocin The metabolism of Propranolol can be increased when combined with Streptozocin.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Propranolol.
Glyburide Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Propranolol.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Propranolol.
Indapamide Indapamide The therapeutic efficacy of Propranolol can be increased when used in combination with Indapamide.
Amoxicillin Amoxicillin Propranolol may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Nafcillin Injection Nafcillin Injection The metabolism of Propranolol can be increased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Propranolol may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may increase the hypotensive activities of Propranolol.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Pentamidine can be increased when used in combination with Propranolol.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Propranolol which could result in a higher serum level.
Labetalol Labetalol Propranolol may increase the orthostatic hypotensive activities of Labetalol.
Auranofin Auranofin Propranolol may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Propranolol.
Gemfibrozil Gemfibrozil The serum concentration of Propranolol can be increased when it is combined with Gemfibrozil.
Guanabenz Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Propranolol.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Propranolol which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Propranolol which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the antihypertensive activities of Propranolol.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Propranolol which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Propranolol.
Enalapril Enalapril The risk or severity of hyperkalemia can be increased when Propranolol is combined with Enalapril.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the antihypertensive activities of Propranolol.
Amiodarone Amiodarone The therapeutic efficacy of Propranolol can be increased when used in combination with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Propranolol which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Propranolol which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin The metabolism of Propranolol can be decreased when combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may decrease the antihypertensive activities of Propranolol.
Diclofenac Diclofenac Diclofenac may decrease the antihypertensive activities of Propranolol.
Fluoxetine Fluoxetine The serum concentration of Propranolol can be increased when it is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of bradycardia can be increased when Nimodipine is combined with Propranolol.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The metabolism of Propranolol can be decreased when combined with Interferon alfa-2b.
Clozapine Clozapine The serum concentration of Propranolol can be increased when it is combined with Clozapine.
Estazolam Estazolam Propranolol may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin Idarubicin The metabolism of Idarubicin can be decreased when combined with Propranolol.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Propranolol is combined with Ofloxacin.
Didanosine Didanosine Propranolol may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Clarithromycin Clarithromycin The metabolism of Propranolol can be decreased when combined with Clarithromycin.
Benazepril Benazepril The risk or severity of hyperkalemia can be increased when Benazepril is combined with Propranolol.
Etodolac Etodolac Etodolac may decrease the antihypertensive activities of Propranolol.
Felodipine Felodipine The risk or severity of bradycardia can be increased when Propranolol is combined with Felodipine.
Fosinopril Fosinopril The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Propranolol.
Nabumetone Nabumetone Nabumetone may decrease the antihypertensive activities of Propranolol.
Pravastatin Pravastatin The metabolism of Pravastatin can be increased when combined with Propranolol.
Quinapril Quinapril The risk or severity of hyperkalemia can be increased when Propranolol is combined with Quinapril.
Ramipril Ramipril Ramipril may increase the hypotensive activities of Propranolol.
Simvastatin Simvastatin The metabolism of Simvastatin can be decreased when combined with Propranolol.
Amlodipine Amlodipine The risk or severity of bradycardia can be increased when Amlodipine is combined with Propranolol.
Teniposide Injection Teniposide Injection The metabolism of Propranolol can be decreased when combined with Teniposide.
Itraconazole Itraconazole The metabolism of Propranolol can be decreased when combined with Itraconazole.
Lisinopril Lisinopril The risk or severity of hyperkalemia can be increased when Propranolol is combined with Lisinopril.
Oxaprozin Oxaprozin Oxaprozin may decrease the antihypertensive activities of Propranolol.
Rifabutin Rifabutin The serum concentration of Propranolol can be decreased when it is combined with Rifabutin.
Sotalol Sotalol Propranolol may increase the arrhythmogenic activities of Sotalol.
Bisoprolol Bisoprolol The risk or severity of adverse effects can be increased when Bisoprolol is combined with Propranolol.
Zolpidem Zolpidem The metabolism of Propranolol can be decreased when combined with Zolpidem.
Doxazosin Doxazosin Propranolol may increase the orthostatic hypotensive activities of Doxazosin.
Terazosin Terazosin Propranolol may increase the orthostatic hypotensive activities of Terazosin.
Isradipine Isradipine The risk or severity of bradycardia can be increased when Isradipine is combined with Propranolol.
Omeprazole Omeprazole The serum concentration of Propranolol can be increased when it is combined with Omeprazole.
Cisapride Cisapride The risk or severity of QTc prolongation can be increased when Propranolol is combined with Cisapride.
Venlafaxine Venlafaxine The metabolism of Propranolol can be decreased when combined with Venlafaxine.
Nizatidine Nizatidine Nizatidine may increase the bradycardic activities of Propranolol.
Fluvoxamine Fluvoxamine The serum concentration of Propranolol can be increased when it is combined with Fluvoxamine.
Nefazodone Nefazodone The serum concentration of Nefazodone can be increased when it is combined with Propranolol.
Lamotrigine Lamotrigine The risk or severity of bradycardia can be increased when Lamotrigine is combined with Propranolol.
Losartan Losartan The serum concentration of Propranolol can be increased when it is combined with Losartan.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Propranolol.
Vinorelbine Injection Vinorelbine Injection The metabolism of Propranolol can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Propranolol which could result in a higher serum level.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Propranolol.
Lansoprazole Lansoprazole The serum concentration of Propranolol can be increased when it is combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Propranolol.
Nicardipine Nicardipine The serum concentration of Propranolol can be increased when it is combined with Nicardipine.
Bupropion Bupropion The metabolism of Propranolol can be decreased when combined with Bupropion.
Ticlopidine Ticlopidine The serum concentration of Propranolol can be increased when it is combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Propranolol.
Metformin Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Propranolol.
Dalteparin Injection Dalteparin Injection The risk or severity of hyperkalemia can be increased when Propranolol is combined with Dalteparin.
Nisoldipine Nisoldipine The risk or severity of bradycardia can be increased when Propranolol is combined with Nisoldipine.
Lamivudine Lamivudine The serum concentration of Lamivudine can be increased when it is combined with Propranolol.
Riluzole Riluzole The metabolism of Riluzole can be decreased when combined with Propranolol.
Amifostine Injection Amifostine Injection Propranolol may increase the hypotensive activities of Amifostine.
Acarbose Acarbose The therapeutic efficacy of Propranolol can be increased when used in combination with Acarbose.
Glimepiride Glimepiride Propranolol may increase the arrhythmogenic activities of Glimepiride.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Propranolol which could result in a higher serum level.
Indinavir Indinavir The metabolism of Propranolol can be decreased when combined with Indinavir.
Ritonavir Ritonavir The serum concentration of Propranolol can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Propranolol.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Meropenem Injection Meropenem Injection Propranolol may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine The serum concentration of Propranolol can be increased when it is combined with Clomipramine.
Zafirlukast Zafirlukast The serum concentration of Propranolol can be increased when it is combined with Zafirlukast.
Fosfomycin Fosfomycin Propranolol may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Propranolol.
Trandolapril Trandolapril The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Propranolol.
Topiramate Topiramate The serum concentration of Propranolol can be increased when it is combined with Topiramate.
Zileuton Zileuton The metabolism of Zileuton can be decreased when combined with Propranolol.
Valsartan Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Propranolol.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin lispro.
Pramipexole Pramipexole The serum concentration of Propranolol can be increased when it is combined with Pramipexole.
Donepezil Donepezil Propranolol may increase the bradycardic activities of Donepezil.
Nelfinavir Nelfinavir The metabolism of Propranolol can be decreased when combined with Nelfinavir.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Propranolol.
Carvedilol Carvedilol The risk or severity of bradycardia can be increased when Carvedilol is combined with Propranolol.
Nilutamide Nilutamide The serum concentration of Propranolol can be increased when it is combined with Nilutamide.
Flutamide Flutamide The metabolism of Propranolol can be decreased when combined with Flutamide.
Selegiline Selegiline Selegiline may increase the hypotensive activities of Propranolol.
Bicalutamide Bicalutamide The serum concentration of Propranolol can be increased when it is combined with Bicalutamide.
Sertraline Sertraline The serum concentration of Propranolol can be increased when it is combined with Sertraline.
Propafenone Propafenone The serum concentration of Propafenone can be increased when it is combined with Propranolol.
Letrozole Letrozole The serum concentration of Propranolol can be increased when it is combined with Letrozole.
Irbesartan Irbesartan The risk or severity of hyperkalemia can be increased when Propranolol is combined with Irbesartan.
Tamsulosin Tamsulosin Propranolol may increase the orthostatic hypotensive activities of Tamsulosin.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Propranolol.
Finasteride Finasteride The metabolism of Finasteride can be decreased when combined with Propranolol.
Quetiapine Quetiapine Propranolol may increase the hypotensive activities of Quetiapine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Propranolol which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Propranolol.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Propranolol which could result in a higher serum level.
Citalopram Citalopram The serum concentration of Propranolol can be increased when it is combined with Citalopram.
Capecitabine Capecitabine Propranolol may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz Efavirenz The serum concentration of Propranolol can be decreased when it is combined with Efavirenz.
Abacavir Abacavir Propranolol may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The serum concentration of Propranolol can be increased when it is combined with Sildenafil.
Pioglitazone Pioglitazone The therapeutic efficacy of Propranolol can be increased when used in combination with Pioglitazone.
Celecoxib Celecoxib Celecoxib may decrease the antihypertensive activities of Propranolol.
Rosiglitazone Rosiglitazone The therapeutic efficacy of Propranolol can be increased when used in combination with Rosiglitazone.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Propranolol.
Thalidomide Thalidomide The serum concentration of Propranolol can be increased when it is combined with Thalidomide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Propranolol which could result in a higher serum level.
Aluminum Hydroxide Aluminum Hydroxide The serum concentration of Propranolol can be decreased when it is combined with Aluminum hydroxide.
Colesevelam Colesevelam Colesevelam can cause a decrease in the absorption of Propranolol resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide Balsalazide may decrease the antihypertensive activities of Propranolol.
Nateglinide Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Propranolol.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Propranolol.
Rabeprazole Rabeprazole The serum concentration of Propranolol can be increased when it is combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Propranolol can be decreased when combined with Terbinafine.

* This branded product is no longer on the market. Generic alternatives may be available.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists